Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Virpax Pharmaceuticals Inc
(NQ:
VRPX
)
0.8284
-0.0206 (-2.43%)
Streaming Delayed Price
Updated: 3:58 PM EDT, Sep 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Virpax Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Virpax Pharmaceuticals Engages New England Investors to Direct Licensing Strategy for Envelta™ in China
January 31, 2023
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax Pharmaceuticals to Utilize Dr. Neil K. Singla to Assist in Development of Probudur™
January 18, 2023
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax Pharmaceuticals Engages Destum Partners to Direct Strategic Global Partnering Efforts
January 10, 2023
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Wednesday
October 19, 2022
On Wednesday, 200 companies hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
May 11, 2022
On Wednesday, 807 companies reached new 52-week lows.
Via
Benzinga
Virpax Engages Physicians Experienced In Childhood Epilepsy To Assist In Development Of NobrXiol
January 04, 2023
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) has engaged two physicians experienced in childhood epilepsy, Dr. Kenneth W. Sommerville and Dr. Lawrence Fried, to support the overall development plan for...
Via
Benzinga
Virpax Pharmaceuticals Engages Dr. Kenneth W. Sommerville and Dr. Lawrence Fried to Assist in Development of NobrXiol™ (formerly VRP324)
January 04, 2023
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
December 30, 2022
Friday's session saw 75 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 21, 2022
Via
Benzinga
Virpax Receives pre-IND Application Guidance From The FDA For Its CBD-Based Drug Candidate For Epilepsy
December 14, 2022
Virpax Pharmaceuticals, Inc.
Via
Benzinga
Virpax Pharmaceuticals Reports on FDA Pre-IND Response for NobrXiol™ (formerly VRP324)
December 14, 2022
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Thursday
November 17, 2022
OnThursday, 137 stocks made new 52-week lows.
Via
Benzinga
Virpax Pharmaceuticals Reports 2022 Third Quarter Results
November 09, 2022
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Tuesday
September 27, 2022
On Tuesday, 456 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
September 26, 2022
Monday saw 825 companies set new 52-week lows.
Via
Benzinga
Dr. Jeffrey Gudin, Chief Medical Officer of Virpax Pharmaceuticals, to Present Poster at World Congress of World Institute of Pain
August 24, 2022
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax Pharmaceuticals Reports 2022 Second Quarter Results and Recent Developments
August 15, 2022
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax Pursues OTC Medical Device Pathway for AnQlar™
July 05, 2022
From
Virpax Pharmaceuticals
Via
Business Wire
Virpax Will Pursue Direct to OTC Pathway for Epoladerm™ for Pain Associated with Osteoarthritis
June 27, 2022
From
Virpax Pharmaceuticals
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2022
June 09, 2022
Upgrades
Via
Benzinga
Virpax Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference
May 19, 2022
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
May 17, 2022
Gainers
Via
Benzinga
Virpax Pharmaceuticals Reports 2022 First Quarter Results and Recent Developments
May 16, 2022
From
Virpax® Pharmaceuticals, Inc.
Via
Business Wire
24 Stocks Moving in Friday's Pre-Market Session
May 06, 2022
Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 35% to $3.47 in pre-market trading. Vinco Ventures set record date as May 18, 2022 For dividend of shares related to Cryptyde deal. The dividend...
Via
Benzinga
Virpax Pharmaceuticals Enters Into CRADA With The U.S. Army Institute of Surgical Research
May 05, 2022
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
92 Biggest Movers From Friday
May 09, 2022
Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the...
Via
Benzinga
55 Stocks Moving In Friday's Mid-Day Session
May 06, 2022
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 24.4% to $7.50. Swvl Holdings 13D Filing from investor Ahmed Sabbah showed a new 6.4% stake in the company.
Via
Benzinga
Virpax Successfully Completes Initial Preclinical Studies for VRP324
April 26, 2022
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
April 29, 2022
On Friday, 213 companies hit new 52-week lows.
Via
Benzinga
Virpax Pharmaceuticals Reports 2021 Year-End Results
March 31, 2022
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.